From obesity to cancer: a review on proposed mechanisms (Q30241069)

12 June 2017

1 reference

title

From obesity to cancer: a review on proposed mechanisms (English)

1 reference

12 June 2017

0 references

Zoya Tahergorabi

1

1 reference

12 June 2017

Majid Khazaei

series ordinal

2

1 reference

12 June 2017

Mitra Moodi

series ordinal

3

1 reference

12 June 2017

Elham Chamani

series ordinal

4

1 reference

12 June 2017

9 November 2016

1 reference

Cell Biochemistry & Function

12 June 2017

1 reference

12 June 2017

34

1 reference

12 June 2017

8

1 reference

12 June 2017

533-545

1 reference

Epidemiology and economic impact of obesity and type 2 diabetes

12 June 2017

1 reference

Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level

21 January 2018

1 reference

Global obesity: trends, risk factors and policy implications

21 January 2018

1 reference

Prevalence and time trends in obesity among adult West African populations: a meta-analysis

21 January 2018

1 reference

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.

21 January 2018

1 reference

The economic burden of obesity worldwide: a systematic review of the direct costs of obesity

21 January 2018

1 reference

Metabolic syndrome and risk of cancer: which link?

21 January 2018

1 reference

Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies

21 January 2018

1 reference

European Code against Cancer 4th Edition: Process of reviewing the scientific evidence and revising the recommendations.

21 January 2018

1 reference

Nutrition and physical activity guidelines for cancer survivors

21 January 2018

1 reference

Obesity and cancer risk: evidence, mechanisms, and recommendations

21 January 2018

1 reference

The role of the IGF system in cancer growth and metastasis: overview and recent insights

21 January 2018

1 reference

A web tool for age-period-cohort analysis of cancer incidence and mortality rates.

21 January 2018

1 reference

Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms

21 January 2018

1 reference

Obesity and cancer risk among white and black United States veterans

21 January 2018

1 reference

Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis

21 January 2018

1 reference

Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer

21 January 2018

1 reference

Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies

21 January 2018

1 reference

Energy restriction during childhood and early adulthood and ovarian cancer risk

21 January 2018

1 reference

Diet-induced obesity promotes colon tumor development in azoxymethane-treated mice

21 January 2018

1 reference

Lessons from mouse models of high-fat diet-induced NAFLD

21 January 2018

1 reference

Obesity and cancer pathogenesis.

21 January 2018

1 reference

Tumor angiogenesis--characteristics of tumor endothelial cells

21 January 2018

1 reference

Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells.

21 January 2018

1 reference

Obesity and Cancer: An Angiogenic and Inflammatory Link

21 January 2018

1 reference

Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages

21 January 2018

1 reference

Effect of Blocking of Neuropeptide Y Y2 Receptor on Tumor Angiogenesis and Progression in Normal and Diet-Induced Obese C57BL/6 Mice.

21 January 2018

1 reference

Angiogenic role of LYVE-1-positive macrophages in adipose tissue.

21 January 2018

1 reference

Adipose tissue vascularization: its role in chronic inflammation

21 January 2018

1 reference

21 January 2018

1 reference

Angiogenesis and chronic inflammation: cause or consequence?

21 January 2018

1 reference

Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation

21 January 2018

1 reference

Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue

21 January 2018

1 reference

Macrophages and the regulation of adipose tissue remodeling

21 January 2018

1 reference

Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer

21 January 2018

1 reference

Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women

21 January 2018

1 reference

Connective tissue growth factor inhibits adipocyte differentiation

21 January 2018

1 reference

Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue.

21 January 2018

1 reference

Angiogenesis as a novel component of inflammatory bowel disease pathogenesis.

21 January 2018

1 reference

Nucleotide metabolism and cell-cell interactions

21 January 2018

1 reference

Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: targeting the inflamed vascular endothelium.

21 January 2018

1 reference

Molecular cloning of the human platelet-derived growth factor receptor beta (PDGFR-beta) promoter and drug targeting of the G-quadruplex-forming region to repress PDGFR-beta expression

21 January 2018

1 reference

Angiopoietins in inflammation and their implication in the development of inflammatory bowel disease. A review.

21 January 2018

1 reference

Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers

21 January 2018

1 reference

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

21 January 2018

1 reference

Obesity and renal cancer: Role of adipokines in the tumor-immune system conflict

21 January 2018

1 reference

Minireview: the year in obesity and cancer

21 January 2018

1 reference

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

21 January 2018

1 reference

Antithrombotic effects of losartan in patients with hypertension complicated by atrial fibrillation: 4A (Angiotensin II Antagonist of platelet Aggregation in patients with Atrial fibrillation), a pilot study

21 January 2018

1 reference

Central nervous system control of food intake and body weight

21 January 2018

1 reference

21 January 2018

Adipokines in obesity

1 reference

Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease

21 January 2018

1 reference

The ins and outs of leptin receptor activation

21 January 2018

1 reference

Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals

21 January 2018

1 reference

Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications

21 January 2018

1 reference

The emerging role of adipokines as mediators of inflammation and immune responses

21 January 2018

1 reference

Role of adipokines in cardiovascular disease

21 January 2018

1 reference

Induction of leptin resistance through direct interaction of C-reactive protein with leptin

21 January 2018

1 reference

Regulation of vascular tone by adipocytes

21 January 2018

1 reference

From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century

21 January 2018

1 reference

Metabolic disturbances linked to obesity: the role of impaired tissue perfusion

21 January 2018

1 reference

Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications

21 January 2018

1 reference

Angiogenesis modulates adipogenesis and obesity

21 January 2018

1 reference

The link between the metabolic syndrome and cancer

21 January 2018

1 reference

Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America.

21 January 2018

1 reference

A single night of sleep deprivation increases ghrelin levels and feelings of hunger in normal-weight healthy men.

21 January 2018

1 reference

Adipose tissue and adipokines: the association with and application of adipokines in obesity

21 January 2018

1 reference

The role of adiponectin in cancer: a review of current evidence

21 January 2018

1 reference

Adiponectin and cardiovascular health: an update

21 January 2018

1 reference

Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner.

21 January 2018

1 reference

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

21 January 2018

1 reference

Adipokines in inflammation and metabolic disease

21 January 2018

1 reference

Adiponectin: more than just another fat cell hormone?

21 January 2018

1 reference

Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease

21 January 2018

1 reference

Adipose tissue as an endocrine organ

21 January 2018

1 reference

The role of apelin in cardiovascular function and heart failure

21 January 2018

1 reference

Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha

21 January 2018

1 reference

The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

21 January 2018

1 reference

The dual role of tumor necrosis factor (TNF) in cancer biology

21 January 2018

1 reference

Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pylori

21 January 2018

1 reference

Tumor necrosis factor: renaissance as a cancer therapeutic?

21 January 2018

1 reference

Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage

21 January 2018

1 reference

TNF-alpha in promotion and progression of cancer

21 January 2018

1 reference

Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells

21 January 2018

1 reference

Inflammation and cancer: IL-6 and STAT3 complete the link.

21 January 2018

1 reference

Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells.

21 January 2018

1 reference

Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells

21 January 2018

1 reference

Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial

21 January 2018

1 reference

Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma

21 January 2018

1 reference

Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells

21 January 2018

1 reference

Siltuximab (CNTO 328): a promising option for human malignancies

21 January 2018

1 reference

Interleukin-6 as a therapeutic target

21 January 2018

1 reference

Transforming growth factor β type II receptor as a marker in diffuse large B cell lymphoma.

21 January 2018

1 reference

Targeting the TGFβ pathway for cancer therapy.

21 January 2018

1 reference

Smad phospho-isoforms direct context-dependent TGF-β signaling

21 January 2018

1 reference

The relevance of the TGF-β Paradox to EMT-MET programs

21 January 2018

1 reference

TGFβ signaling in head and neck squamous cell carcinoma

21 January 2018

1 reference

The dynamic roles of TGF-β in cancer

21 January 2018

1 reference

Complexities of TGF-β targeted cancer therapy

21 January 2018

1 reference

Biology of interleukin-10.

21 January 2018

1 reference

Regulation and functions of the IL-10 family of cytokines in inflammation and disease

21 January 2018

1 reference

Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation

21 January 2018

1 reference

IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines

21 January 2018

1 reference

Progesterone receptors, their isoforms and progesterone regulated transcription

21 January 2018

1 reference

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

The Regulation of Steroid Action by Sulfation and Desulfation

21 January 2018

1 reference

Estrogenic regulation of signaling pathways and homeobox genes during rat prostate development

21 January 2018

1 reference

Estrogen action and prostate cancer

21 January 2018

1 reference

Sex differences and sex steroids in lung health and disease

21 January 2018

1 reference

Research resource: estrogen-driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasia

21 January 2018

1 reference

Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor

21 January 2018

1 reference

The evolving role of oestrogens and their receptors in the development and progression of prostate cancer

21 January 2018

1 reference

A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver

21 January 2018

1 reference

High progesterone receptor expression in prostate cancer is associated with clinical failure

21 January 2018

1 reference

Sex steroid receptors in human lung diseases

21 January 2018

1 reference

Reflections on the discovery and significance of estrogen receptor beta

21 January 2018

1 reference

Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer

21 January 2018

1 reference

Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms

21 January 2018

1 reference

Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma

21 January 2018

1 reference

Regulation of apoptosis by insulin-like growth factor (IGF)-I.

21 January 2018

1 reference

Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms.

21 January 2018

1 reference

The proliferating role of insulin and insulin-like growth factors in cancer

21 January 2018

1 reference

Q&A: Cancer: clues from cell metabolism

21 January 2018

1 reference

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

Targeting cancer metabolism: a therapeutic window opens

21 January 2018

1 reference

Mitochondrial metabolism and cancer

21 January 2018

1 reference

Fatty acid synthase as a potential therapeutic target in cancer

21 January 2018

1 reference

Cancer metabolism: current perspectives and future directions

21 January 2018

1 reference

Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress

21 January 2018

1 reference

Lipid catabolism via CPT1 as a therapeutic target for prostate cancer

21 January 2018

1 reference

Role of LKB1 in lung cancer development

21 January 2018

1 reference

Targeting AMPK: a new therapeutic opportunity in breast cancer

21 January 2018

1 reference

Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase

21 January 2018

1 reference

Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development

21 January 2018

1 reference

PI3K/PTEN signaling in angiogenesis and tumorigenesis

21 January 2018

1 reference

mTOR links oncogenic signaling to tumor cell metabolism

21 January 2018

1 reference

Molecular mechanisms of cancer development in obesity

21 January 2018

1 reference

Parallel progression of primary tumours and metastases

21 January 2018

1 reference

Epithelial ovarian cancer experimental models.

21 January 2018

1 reference

Obesity and cancer--mechanisms underlying tumour progression and recurrence

21 January 2018

1 reference

Loss of adipocyte specification and necrosis augment tumor-associated inflammation

21 January 2018

1 reference

Metabolic functions of FABPs--mechanisms and therapeutic implications

21 January 2018

1 reference

Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability

21 January 2018

1 reference

Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.

21 January 2018

1 reference

Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis

21 January 2018

1 reference

The role of monoacylglycerol lipase (MAGL) in the cancer progress

21 January 2018

1 reference

Insulin resistance and cancer: the role of insulin and IGFs

21 January 2018

1 reference

Cellular fatty acid metabolism and cancer

21 January 2018

1 reference

Metabolic genes in cancer: their roles in tumor progression and clinical implications

21 January 2018

1 reference

Tumor cell metabolism: cancer's Achilles' heel

21 January 2018

1 reference

Cholesterol, statins and cancer

21 January 2018

1 reference

Understanding the benefit of metformin use in cancer treatment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CBF.3229

1 reference

12 June 2017

1 reference